SELLAS Life Sciences (SLS) Free Cash Flow (2019 - 2024)
Historic Free Cash Flow for SELLAS Life Sciences (SLS) over the last 9 years, with Q3 2024 value amounting to -$7.8 million.
- SELLAS Life Sciences' Free Cash Flow fell 1326.18% to -$7.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$33.1 million, marking a year-over-year decrease of 421.27%. This contributed to the annual value of -$35.4 million for FY2024, which is 1270.93% down from last year.
- According to the latest figures from Q3 2024, SELLAS Life Sciences' Free Cash Flow is -$7.8 million, which was down 1326.18% from -$9.7 million recorded in Q2 2024.
- SELLAS Life Sciences' Free Cash Flow's 5-year high stood at $3.4 million during Q4 2020, with a 5-year trough of -$12.1 million in Q1 2023.
- In the last 5 years, SELLAS Life Sciences' Free Cash Flow had a median value of -$5.9 million in 2021 and averaged -$6.3 million.
- In the last 5 years, SELLAS Life Sciences' Free Cash Flow plummeted by 24532.71% in 2021 and then skyrocketed by 3037.3% in 2022.
- SELLAS Life Sciences' Free Cash Flow (Quarter) stood at $3.4 million in 2020, then crashed by 245.33% to -$5.0 million in 2021, then fell by 3.54% to -$5.2 million in 2022, then increased by 6.35% to -$4.8 million in 2023, then plummeted by 61.78% to -$7.8 million in 2024.
- Its Free Cash Flow was -$7.8 million in Q3 2024, compared to -$9.7 million in Q2 2024 and -$10.8 million in Q1 2024.